StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$1.96+0.07 (+3.70%)

Close on Nov 17, 2026Market cap $18.90MP/E –Yield –

Edesa Biotech cash

Cash and short-term investments held at the end of each period.

Edesa Biotech's cash was $10.30M at Jun 30, 2026. For fiscal 2025 it was $10.79M, up 940.4% from the year before. Over ten years it grew -2.5% a year on average. The highest annual figure on record is $13.89M in fiscal 2014.

Annual cash

PeriodPeriod endValueChange
FY2025Sep 30, 2025$10.79M+940.4%
FY2024Sep 30, 2024$1.04M-80.7%
FY2023Sep 30, 2023$5.36M-24.4%
FY2022Sep 30, 2022$7.09M-9.5%
FY2021Sep 30, 2021$7.84M+8.7%
FY2020Sep 30, 2020$7.21M+43.4%
FY2019Sep 30, 2019$5.03M-48.7%
FY2018Sep 30, 2018$9.81M+49.4%
FY2017Sep 30, 2017$6.57M-42.4%
FY2016Sep 30, 2016$11.41M-17.9%
FY2014Aug 31, 2014$13.89M+76.7%
FY2013Aug 31, 2013$7.86M+686.8%
FY2012Aug 31, 2012$999.00K-75.9%
FY2011Aug 31, 2011$4.15M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$10.30M-16.9%
Q2 FY2026CQ1 2026Mar 31, 2026$10.00M-28.1%
Q1 FY2026CQ4 2025Dec 31, 2025$12.10M+656.3%
Q4 FY2025CQ3 2025Sep 30, 2025$10.79M+940.4%
Q3 FY2025CQ2 2025Jun 30, 2025$12.40M+507.6%
Q2 FY2025CQ1 2025Mar 31, 2025$13.90M+396.5%
Q1 FY2025CQ4 2024Dec 31, 2024$1.60M-62.5%
Q4 FY2024CQ3 2024Sep 30, 2024$1.04M-80.7%
Q3 FY2024CQ2 2024Jun 30, 2024$2.04M-68.4%
Q2 FY2024CQ1 2024Mar 31, 2024$2.80M-62.5%
Q1 FY2024CQ4 2023Dec 31, 2023$4.27M-48.4%
Q4 FY2023CQ3 2023Sep 30, 2023$5.36M-24.4%
Q3 FY2023CQ2 2023Jun 30, 2023$6.46M-49.6%
Q2 FY2023CQ1 2023Mar 31, 2023$7.47M-53.0%
Q1 FY2023CQ4 2022Dec 31, 2022$8.27M+40.6%
Q4 FY2022CQ3 2022Sep 30, 2022$7.09M-9.5%
Q3 FY2022CQ2 2022Jun 30, 2022$12.81M+59.1%
Q2 FY2022CQ1 2022Mar 31, 2022$15.89M+44.9%
Q1 FY2022CQ4 2021Dec 31, 2021$5.88M-6.7%
Q4 FY2021CQ3 2021Sep 30, 2021$7.84M+8.7%
Q3 FY2021CQ2 2021Jun 30, 2021$8.05M+42.8%
Q2 FY2021CQ1 2021Mar 31, 2021$10.97M+56.9%
Q1 FY2021CQ4 2020Dec 31, 2020$6.31M+45.7%
Q4 FY2020CQ3 2020Sep 30, 2020$7.21M+43.4%
Q3 FY2020CQ2 2020Jun 30, 2020$5.64M-11.4%
Q2 FY2020CQ1 2020Mar 31, 2020$6.99M+129.8%
Q1 FY2020CQ4 2019Dec 31, 2019$4.33M-12.9%
Q4 FY2019CQ3 2019Sep 30, 2019$5.03M-48.7%
Q3 FY2019CQ2 2019Jun 30, 2019$6.36M-32.3%
Q2 FY2019CQ1 2019Mar 31, 2019$3.04M-19.8%
Q1 FY2019CQ4 2018Dec 31, 2018$4.97M-17.2%
Q4 FY2018CQ3 2018Sep 30, 2018$9.81M+49.4%
Q3 FY2018CQ2 2018Jun 30, 2018$9.40M+23.0%
Q2 FY2018CQ1 2018Mar 31, 2018$3.79M-55.9%
Q1 FY2018CQ4 2017Dec 31, 2017$6.00M-39.3%
Q4 FY2017CQ3 2017Sep 30, 2017$6.57M-42.4%
Q3 FY2017CQ2 2017Jun 30, 2017$7.65M–
Q2 FY2017CQ1 2017Mar 31, 2017$8.60M–
Q1 FY2017CQ4 2016Dec 31, 2016$9.88M–
Q4 FY2016CQ3 2016Sep 30, 2016$11.41M–

More Edesa Biotech figures

See a number that looks wrong?